Search clinical trials for: hrIL-2 placebo

Total 66262 results

Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Unknown

A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Assistance Publique - Hôpitaux de Paris
Iltoo Pharma

Completed

Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes (DIABIL-2)

Type 1 Diabetes

Belgium, France, Germany, Netherlands, Sweden, Switzerland
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

China
Crucell Holland BV

Completed

A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

Rabies

United States
The First Affiliated Hospital with Nanjing Medical...

Unknown

Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB (rhIL-2)

MDR TB

China
Celularity Incorporated

Completed

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Multiple Myeloma

United States
HilleVax

Active, not recruiting

Efficacy and Safety of Two Doses of HIL-214 in Children

Gastroenteritis

Dominican Republic, United States, Peru, Colombia, Honduras, Panama, Puerto Rico
HilleVax

Active, not recruiting

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Gastroenteritis

United States, Panama, Puerto Rico
University of Chicago

Completed

Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma

Metastatic Melanoma

United States
NeoImmuneTech
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Terminated

A Trial of NT-I7 in COVID-19 (SPESELPIS)

COVID-19

United States
HilleVax

Active, not recruiting

Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants

Gastroenteritis

Japan
University of South Florida

Unknown

Hemodynamic Assessment of Distal Revascularization Interval Ligation (DRIL)

Chronic Kidney Diseases | Arterio-Venous Fistula | Steal Syndrome

United States
University Hospital Regensburg
University of Regensburg

Completed

Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus (PUL)

Quality of Life

Germany
National Taiwan University Hospital

Not yet recruiting

Swallowing Evaluation by HRIM in Patients With Cervical Spondylosis

Upper Esophageal Sphincter Relaxing Pressure
Alaunos Therapeutics

Terminated

A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG

Diffuse Intrinsic Pontine Glioma | Pediatric Brain Tumor

United States
Kamada, Ltd.
Kedrion S.p.A.

Completed

Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies

Rabies

United States
Second Xiangya Hospital of Central South University

Recruiting

Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris

Pemphigus Vulgaris

China
Cytheris SA

Completed

Safety Study of IL-7 in HIV-infected Patients (Inspire)

HIV Infections | Lymphopenia

United States, France, Canada, Italy
Cytheris, Inc.

Completed

Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

AML | MDS | CML

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Purified Vero Rabies Vaccine

Rabies Virus

United States
Antisoma Research

Completed

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Metastatic Renal Cell Carcinoma | Metastatic Malignant Melanoma

United Kingdom, New Zealand
Crucell Holland BV

Completed

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Rabies

Philippines
Vanderbilt University Medical Center
American Heart Association

Active, not recruiting

2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation

Atrial Fibrillation

United States
Children's Hospital Medical Center, Cincinnati
Nationwide Children's Hospital; University of Cincinnati; Connecticut Children... and other collaborators

Recruiting

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy (PRIME)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

United States
Vanderbilt University Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

Familial Hypercholesterolemia

United States
Metabolic Technologies Inc.
National Institute on Aging (NIA); Vanderbilt University

Completed

2-HOBA: Multiple Dosing Study in Older Adults (2-HOBA)

Older Adults

United States
Metabolic Technologies Inc.
National Institute on Aging (NIA); Vanderbilt University

Completed

2-HOBA: Multiple Dosing Study in Healthy Humans (2-HOBA)

Healthy Volunteers

United States
Massachusetts General Hospital
National Institute on Aging (NIA)

Not yet recruiting

Healthy Activities Improve Lives (HAIL) (HAIL)

Physical Activity
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers

Gastroparesis

United States
Chonbuk National University Hospital
GS Engineering & Construction

Completed

Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects

Obesity
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis

Ulcerative Colitis | Inflammatory Bowel Disease
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
Novartis Pharmaceuticals

Completed

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Primary Biliary Cholangitis

United States, Germany, Russian Federation, Canada, United Kingdom, Poland
NuBiyota

Recruiting

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression

Anxiety | Major Depressive Disorder

Canada
National Institute of Allergy and Infectious Diseases...
Chiron Corporation

Completed

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy (ESPRIT)

HIV Infections

United States, Brazil, Australia, Argentina, Austria, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Japan, Morocco, Netherlands, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, Thailand, United Kingdom
Royal Berkshire NHS Foundation Trust
University of Reading

Recruiting

Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC) (PRInCE-UC)

Ulcerative Colitis

United Kingdom
Aposcience AG
FGK Clinical Research GmbH

Completed

A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

Diabetic Foot Ulcer (DFU)

Austria, Czechia, Germany, Poland
China Medical University Hospital
Ministry of Science and Technology, Taiwan

Completed

DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia

Schizophrenia

Taiwan
AB2 Bio Ltd.

Active, not recruiting

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension

NLRC4-MAS | XIAP Deficiency

United States, Canada, Germany
Alaunos Therapeutics

Completed

Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102

Glioblastoma

United States
Vitae Pharmaceuticals Inc., an Allergan affiliate

Completed

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

Psoriasis

United States
German Institute of Human Nutrition
German Center for Diabetes Research; Firma Rettenmeier & Söhne (Company)

Unknown

Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes (DiNA-S DiNA-F)

Type 2 Diabetes

Germany
Tunitas Therapeutics, Inc.
Tunitas Therapeutics Australia Pty Ltd

Terminated

Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects

Allergy and Immunology

Australia
Second Xiangya Hospital of Central South University

Not yet recruiting

Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria

Chronic Spontaneous Urticaria

China
Shenzhen Precision Health Food Technology Co. Ltd...

Completed

The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

Diabetes | Sugar; Blood, High

China
University of Maryland, Baltimore
National Cancer Institute (NCI)

Recruiting

Implementation of Anal Cancer Screening and Treatment in Nigeria (IMPACT)

Education, Medical

Nigeria
AstraZeneca

Active, not recruiting

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

COVID-19, SARS-CoV-2

Japan
Hoffmann-La Roche

Completed

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus Type 2

United States, Hungary, Poland, Bulgaria, Croatia, Mexico, Guatemala
Universidad de Murcia

Completed

Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus (lichenPlanus)

Oral Lichen Planus

Spain

Search clinical trials for: hrIL-2 placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations